Last update Oct. 11, 2017
Very Low Risk
A corticosteroid with a mainly glucocorticoid action and moderate anti-inflammatory effects (ATC D07AB), slightly higher than that of prednisolone (ATC D07AA).
Its topical dermatological use is indicated in the treatment of various types of dermatitis.
This comment is about the TOPICAL USE of triamcinolone.
Limited absorption through the skin and even mucous (Ramadas 2016, Meynadier 1981, Rasmussen 1978) makes it unlikely that significant amounts will pass into breast milk.
If it is required to treat eczema or dermatoses of the nipple, it is advisable to choose the mildest corticoid, apply it just after the feed is finished so that it has been reabsorbed before the next feed, if it is necessary residues can be removed with a gauze and do not use it for more than a week after.
Mineralocorticoid intoxication has occurred in an infant due to continuous application of a corticoid to the nipple (De Stefano 1983).
It is advisable to avoid application to the nipple of creams, gels and other topically-applied products that contain paraffin (mineral oil) so that the infant does not absorb them (Concin 2008, Noti 2003).
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM